The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 09, 2018
Filed:
Apr. 01, 2016
Applicants:
University of Massachusetts, Boston, MA (US);
Beth Israel Deaconess Medical Center, Inc., Boston, MA (US);
Inventors:
Anastasia Khvorova, Westborough, MA (US);
Melissa Moore, Chestnut Hill, MA (US);
Anton A. Turanov, Boston, MA (US);
Ananth Karumanchi, Chestnut Hill, MA (US);
Assignees:
UNIVERSITY OF MASSACHUSETTS, Boston, MA (US);
BETH ISRAEL DEACONESS MEDICAL CENTER, Boston, MA (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/713 (2006.01); C12N 15/113 (2010.01);
U.S. Cl.
CPC ...
C12N 15/1138 (2013.01); A61K 31/713 (2013.01); C12N 15/1137 (2013.01); C12N 2310/14 (2013.01); C12N 2310/315 (2013.01); C12N 2310/321 (2013.01); C12N 2310/322 (2013.01); C12N 2310/344 (2013.01); C12N 2310/346 (2013.01); C12N 2310/351 (2013.01); C12N 2310/50 (2013.01);
Abstract
This disclosure relates to novel targets for angiogenic disorders. Novel oligonucleotides are also provided. Methods of using the novel oligonucleotides for the treatment of angiogenic disorders (e.g., preeclampsia) are also provided.